Butabarbital
Generic name: Pronounced as (byoo ta bar' bi tal)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 04/15/2019
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Other names
- Drug interactions
Why is this medication prescribed?
Butabarbital is used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep). It is also used to relieve anxiety, including anxiety before surgery. Butabarbital is in a class of medications called barbiturates. It works by slowing activity in the brain.
How should this medicine be used?
Butabarbital comes as a tablet and a solution (liquid) to take by mouth. When butabarbital is used to treat insomnia, it is usually taken at bedtime as needed for sleep. When butabarbital is used to relieve anxiety before surgery, it is usually taken 60 to 90 minutes before surgery. When butabarbital is used to relieve anxiety, it is usually taken three to four times a day. If you are taking butabarbital on a regular schedule, take it at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take butabarbital exactly as directed.
Your sleep problems should improve within 7 to 10 days after you start taking butabarbital. Call your doctor if your sleep problems do not improve during this time, if they get worse at any time during your treatment, or if you notice any changes in your thoughts or behavior.
Butabarbital should normally be taken for short periods of time. If you take butabarbital for 2 weeks or longer, butabarbital may not help you sleep as well or control your anxiety as it did when you first began to take the medication. If you take butabarbital for a long time, you also may develop dependence ('addiction,' a need to continue taking the medication) on butabarbital. Talk to your doctor about the risks of taking butabarbital for 2 weeks or longer. Do not take a larger dose of butabarbital, take it more often, or take it for a longer time than prescribed by your doctor.
Do not stop taking butabarbital without talking to your doctor. Your doctor will probably decrease your dose gradually. If you suddenly stop taking butabarbital, you may develop anxiety, muscle twitching, uncontrollable shaking of your hands or fingers, weakness, dizziness, changes in vision, nausea, vomiting, or difficulty falling asleep or staying asleep, or you may experience more severe withdrawal symptoms such as seizures or extreme confusion.
Other uses for this medicine
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking butabarbital,
-
tell your doctor and pharmacist if you are allergic to butabarbital; other barbiturates such as amobarbital (Amytal, in Tuinal), pentobarbital, phenobarbital, or secobarbital (Seconal); tartrazine (a yellow dye found in some foods and medications); aspirin; or any other medications. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: anticoagulants ('blood thinners') such as warfarin (Coumadin, Jantoven); antihistamines; doxycycline (Doryx, Vibramycin; Vibra-tabs); griseofulvin (Fulvicin-U/F, Grifulvin V, Gris-PEG); hormone replacement therapy; monoamine oxidase (MAO) inhibitors such as isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl, Emsam, Zelapar), and tranylcypromine (Parnate); medications for depression, pain, colds or allergies; muscle relaxants; certain medications for seizures such as phenytoin (Dilantin) and valproic acid (Depakene); oral steroids such as dexamethasone, methylprednisolone (Medrol), and prednisone; sedatives; sleeping pills; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor if you have or have ever had porphyria (condition in which certain natural substances build up in the body and may cause stomach pain, changes in thinking and behavior, and other symptoms). Your doctor will probably tell you not to take butabarbital.
-
tell your doctor if you drink or have ever drunk large amounts of alcohol, use or have ever used street drugs, or have overused prescription medications. Also tell your doctor if you have ever thought about killing yourself or tried to do so and if you have or have ever had asthma or any condition that causes shortness of breath or difficulty breathing; depression; seizures; or kidney or liver disease.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking butabarbital, call your doctor immediately. Butabarbital may harm the fetus.
-
you should know that butabarbital may decrease the effectiveness of hormonal contraceptives (birth control pills, patches, rings, injections, implants, or intrauterine devices). Talk to your doctor about methods of birth control that will work for you during your treatment with butabarbital. Tell your doctor if you have a missed period or think you may be pregnant while you are taking butabarbital.
-
talk to your doctor about the risks and benefits of taking this medication if you are 65 years of age or older. Older adults should not usually take butabarbital because it is not as safe or effective as other medication(s) that can be used to treat the same condition.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking butabarbital.
-
you should know that this medication may make you drowsy during the daytime, may decrease your mental alertness, and may increase the risk that you could fall. Take extra care to be sure you do not fall, especially if you get out of bed in the middle of the night. Do not drive a car or operate machinery until you know how this medication affects you.
-
do not drink alcohol during your treatment with butabarbital. Alcohol can make the side effects of butabarbital worse.
-
you should know that some people who took medications for sleep got out of bed and drove their cars, prepared and ate food, had sex, made phone calls, or were involved in other activities while partially asleep. After they woke up, these people were usually unable to remember what they had done. Call your doctor right away if you find out that you have been driving or doing anything else while you were sleeping.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
If you are taking butabarbital on a regular basis, take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
-
Butabarbital may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
drowsiness
-
difficulty falling asleep or staying asleep
-
nightmares
-
headache
-
dizziness
-
depression
-
nervousness
-
agitation
-
excitement
-
confusion
-
restlessness
-
nausea
-
vomiting
-
constipation
-
-
Some side effects can be serious. If you experience any of the following symptoms, or those listed in the SPECIAL PRECAUTIONS sections, call your doctor immediately:
-
hallucinating (seeing things or hearing voices that do not exist)
-
slow, shallow breathing
-
slow heartbeat
-
fainting
-
hives
-
rash
-
itching
-
swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs
-
difficulty breathing or swallowing
-
hoarseness
-
-
Butabarbital may cause other side effects. Tell your doctor if you have any unusual problems while you are taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
What should I know about STORAGE and DISPOSAL of this medication?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include:
-
unsteadiness
-
slurred speech
-
uncontrollable eye movements
-
confusion
-
poor judgment
-
irritability
-
difficulty falling asleep or staying asleep
-
fast, slowed or shallow breathing
-
narrowed pupils (black circles in the middle of the eye)
-
decreased urination
-
fast heartbeat
-
low body temperature
-
coma (loss of consciousness for a periol of time)
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your response to butabarbital.
Do not let anyone else take your medication. Butabarbital is a controlled substance. Prescriptions may be refilled only a limited number of times; ask your pharmacist if you have any questions.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Dolasetron | Dolasetron The risk or severity of adverse effects can be increased when Butabarbital is combined with Dolasetron. |
Aminophylline | Aminophylline The therapeutic efficacy of Butabarbital can be decreased when used in combination with Aminophylline. |
Bisacodyl | Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Butabarbital. |
Cilostazol | Cilostazol Butabarbital may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Diphenoxylate | Diphenoxylate The risk or severity of adverse effects can be increased when Butabarbital is combined with Diphenoxylate. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Butabarbital may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level. |
Fenofibrate | Fenofibrate Butabarbital may decrease the excretion rate of Fenofibrate which could result in a higher serum level. |
Guanfacine | Guanfacine The risk or severity of adverse effects can be increased when Butabarbital is combined with Guanfacine. |
Magnesium Hydroxide | Magnesium Hydroxide Butabarbital may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Magnesium Oxide | Magnesium Oxide The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Butabarbital. |
Mycophenolate | Mycophenolate Butabarbital may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level. |
Naratriptan | Naratriptan The risk or severity of adverse effects can be increased when Butabarbital is combined with Naratriptan. |
Olsalazine | Olsalazine Olsalazine may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Paregoric | Paregoric The risk or severity of adverse effects can be increased when Butabarbital is combined with Morphine. |
Penbutolol | Penbutolol Butabarbital may increase the hypotensive activities of Acebutolol. |
Pentazocine | Pentazocine The risk or severity of adverse effects can be increased when Butabarbital is combined with Pentazocine. |
Polyethylene glycol-electrolyte solution (PEG-ES) | Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Butabarbital. |
Potassium | Potassium Potassium may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone Butabarbital may decrease the excretion rate of Prednisone which could result in a higher serum level. |
Psyllium | Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Butabarbital. |
Ranitidine | Ranitidine Butabarbital may decrease the excretion rate of Ranitidine which could result in a higher serum level. |
Reserpine | Reserpine The risk or severity of adverse effects can be increased when Reserpine is combined with Butabarbital. |
Rizatriptan | Rizatriptan The risk or severity of adverse effects can be increased when Butabarbital is combined with Rizatriptan. |
Sumatriptan | Sumatriptan The risk or severity of adverse effects can be increased when Butabarbital is combined with Sumatriptan. |
Tacrolimus | Tacrolimus Tacrolimus may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Tizanidine | Tizanidine The risk or severity of adverse effects can be increased when Butabarbital is combined with Tizanidine. |
Zolmitriptan | Zolmitriptan The risk or severity of adverse effects can be increased when Butabarbital is combined with Zolmitriptan. |
Ampicillin Injection | Ampicillin Injection Butabarbital may decrease the excretion rate of Ampicillin which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection The serum concentration of Doxycycline can be decreased when it is combined with Butabarbital. |
Fluconazole Injection | Fluconazole Injection Fluconazole may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Foscarnet Injection | Foscarnet Injection Foscarnet may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Hydromorphone Injection | Hydromorphone Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Hydromorphone. |
Levofloxacin Injection | Levofloxacin Injection Butabarbital may decrease the excretion rate of Levofloxacin which could result in a higher serum level. |
Meperidine Injection | Meperidine Injection Butabarbital may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Meperidine. |
Metoclopramide Injection | Metoclopramide Injection The risk or severity of sedation can be increased when Metoclopramide is combined with Butabarbital. |
Morphine Injection | Morphine Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Morphine. |
Pamidronate Injection | Pamidronate Injection Pamidronic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Vancomycin Injection | Vancomycin Injection Butabarbital may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Altretamine | Altretamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Butabarbital. |
Cefuroxime | Cefuroxime Cefuroxime may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Cyclosporine | Cyclosporine The metabolism of Butabarbital can be increased when combined with Cyclosporine. |
Ondansetron | Ondansetron The risk or severity of adverse effects can be increased when Butabarbital is combined with Ondansetron. |
Granisetron | Granisetron The risk or severity of adverse effects can be increased when Butabarbital is combined with Granisetron. |
Torsemide | Torsemide Torasemide may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Olanzapine | Olanzapine The risk or severity of adverse effects can be increased when Butabarbital is combined with Olanzapine. |
Alosetron | Alosetron The risk or severity of adverse effects can be increased when Butabarbital is combined with Alosetron. |
Entacapone | Entacapone The risk or severity of adverse effects can be increased when Butabarbital is combined with Entacapone. |
Eprosartan | Eprosartan Butabarbital may increase the hypotensive activities of Eprosartan. |
Meloxicam | Meloxicam Meloxicam may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Oxcarbazepine | Oxcarbazepine The risk or severity of adverse effects can be increased when Butabarbital is combined with Oxcarbazepine. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Telmisartan | Telmisartan Butabarbital may increase the hypotensive activities of Telmisartan. |
Temozolomide | Temozolomide Butabarbital may decrease the excretion rate of Temozolomide which could result in a higher serum level. |
Zaleplon | Zaleplon The risk or severity of adverse effects can be increased when Butabarbital is combined with Zaleplon. |
Desloratadine | Desloratadine The risk or severity of adverse effects can be increased when Butabarbital is combined with Desloratadine. |
Linezolid | Linezolid The risk or severity of adverse effects can be increased when Butabarbital is combined with Linezolid. |
Rivastigmine | Rivastigmine The therapeutic efficacy of Butabarbital can be decreased when used in combination with Rivastigmine. |
Trimipramine | Trimipramine The risk or severity of adverse effects can be increased when Butabarbital is combined with Trimipramine. |
Glycopyrrolate | Glycopyrrolate Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium. |
Perindopril | Perindopril Perindopril may increase the hypotensive activities of Butabarbital. |
Tenofovir | Tenofovir Tenofovir may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Eplerenone | Eplerenone Eplerenone may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Escitalopram | Escitalopram The risk or severity of adverse effects can be increased when Butabarbital is combined with Escitalopram. |
Olmesartan | Olmesartan Butabarbital may increase the hypotensive activities of Olmesartan. |
Zonisamide | Zonisamide The risk or severity of adverse effects can be increased when Butabarbital is combined with Zonisamide. |
Aripiprazole | Aripiprazole The risk or severity of adverse effects can be increased when Butabarbital is combined with Aripiprazole. |
Atomoxetine | Atomoxetine The risk or severity of adverse effects can be increased when Butabarbital is combined with Atomoxetine. |
Dexmethylphenidate | Dexmethylphenidate The risk or severity of adverse effects can be increased when Butabarbital is combined with Dexmethylphenidate. |
Atazanavir | Atazanavir Atazanavir may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Almotriptan | Almotriptan The risk or severity of adverse effects can be increased when Butabarbital is combined with Almotriptan. |
Eletriptan | Eletriptan The risk or severity of adverse effects can be increased when Eletriptan is combined with Butabarbital. |
Mefloquine | Mefloquine The therapeutic efficacy of Butabarbital can be decreased when used in combination with Mefloquine. |
Polyethylene Glycol 3350 | Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Butabarbital. |
Emtricitabine | Emtricitabine Butabarbital may decrease the excretion rate of Emtricitabine which could result in a higher serum level. |
Memantine | Memantine The therapeutic efficacy of Butabarbital can be decreased when used in combination with Memantine. |
Tegaserod | Tegaserod The therapeutic efficacy of Tegaserod can be decreased when used in combination with Butabarbital. |
Tadalafil | Tadalafil Butabarbital may decrease the excretion rate of Tadalafil which could result in a higher serum level. |
Frovatriptan | Frovatriptan The risk or severity of adverse effects can be increased when Butabarbital is combined with Frovatriptan. |
Apomorphine Injection | Apomorphine Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Apomorphine. |
Protriptyline | Protriptyline The risk or severity of adverse effects can be increased when Butabarbital is combined with Protriptyline. |
Duloxetine | Duloxetine The risk or severity of adverse effects can be increased when Butabarbital is combined with Duloxetine. |
Tinidazole | Tinidazole Butabarbital may decrease the excretion rate of Tinidazole which could result in a higher serum level. |
Trospium | Trospium Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Trospium. |
Cefditoren | Cefditoren Butabarbital may decrease the excretion rate of Cefdinir which could result in a higher serum level. |
Cyanocobalamin Injection | Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Eszopiclone | Eszopiclone The risk or severity of CNS depression can be increased when Butabarbital is combined with Eszopiclone. |
Ganciclovir | Ganciclovir Butabarbital may decrease the excretion rate of Ganciclovir which could result in a higher serum level. |
Ribavirin | Ribavirin Butabarbital may decrease the excretion rate of Ribavirin which could result in a higher serum level. |
Solifenacin | Solifenacin Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Solifenacin. |
Valganciclovir | Valganciclovir Butabarbital may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Voriconazole | Voriconazole The serum concentration of Voriconazole can be decreased when it is combined with Butabarbital. |
Adefovir | Adefovir Adefovir may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Dextroamphetamine | Dextroamphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Butabarbital. |
Sodium Oxybate | Sodium Oxybate Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
Isocarboxazid | Isocarboxazid The risk or severity of adverse effects can be increased when Butabarbital is combined with Isocarboxazid. |
Ramelteon | Ramelteon The risk or severity of adverse effects can be increased when Butabarbital is combined with Ramelteon. |
Darifenacin | Darifenacin Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Darifenacin. |
Fentanyl | Fentanyl The risk or severity of adverse effects can be increased when Butabarbital is combined with Fentanyl. |
Pregabalin | Pregabalin The therapeutic efficacy of Butabarbital can be increased when used in combination with Pregabalin. |
Felbamate | Felbamate The serum concentration of Felbamate can be increased when it is combined with Butabarbital. |
Ranolazine | Ranolazine Butabarbital may decrease the excretion rate of Ranolazine which could result in a higher serum level. |
Rasagiline | Rasagiline The risk or severity of adverse effects can be increased when Butabarbital is combined with Rasagiline. |
Sitagliptin | Sitagliptin Butabarbital may decrease the excretion rate of Sitagliptin which could result in a higher serum level. |
Varenicline | Varenicline Butabarbital may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Albuterol | Albuterol Butabarbital may decrease the excretion rate of Salbutamol which could result in a higher serum level. |
Paliperidone | Paliperidone The risk or severity of adverse effects can be increased when Butabarbital is combined with Paliperidone. |
Clofarabine Injection | Clofarabine Injection Butabarbital may increase the hypotensive activities of Clofarabine. |
Lubiprostone | Lubiprostone Butabarbital may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Aliskiren | Aliskiren Butabarbital may increase the hypotensive activities of Aliskiren. |
Pemetrexed Injection | Pemetrexed Injection Butabarbital may decrease the excretion rate of Pemetrexed which could result in a higher serum level. |
Dimenhydrinate | Dimenhydrinate The risk or severity of adverse effects can be increased when Butabarbital is combined with Dimenhydrinate. |
Nabilone | Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Butabarbital. |
Sorafenib | Sorafenib Butabarbital may decrease the excretion rate of Sorafenib which could result in a higher serum level. |
Dronabinol | Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Butabarbital. |
Levocetirizine | Levocetirizine The risk or severity of adverse effects can be increased when Butabarbital is combined with Levocetirizine. |
Pegaptanib Injection | Pegaptanib Injection Butabarbital may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Azacitidine Injection | Azacitidine Injection Butabarbital may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Paclitaxel (with polyoxyethylated castor oil) Injection | Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Butabarbital. |
Lenalidomide | Lenalidomide Butabarbital may decrease the excretion rate of Lenalidomide which could result in a higher serum level. |
Budesonide | Budesonide Butabarbital may decrease the excretion rate of Budesonide which could result in a higher serum level. |
Chloramphenicol Injection | Chloramphenicol Injection The metabolism of Butabarbital can be decreased when combined with Chloramphenicol. |
Desmopressin | Desmopressin Desmopressin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Betaine | Betaine The therapeutic efficacy of Butabarbital can be decreased when used in combination with Glycine betaine. |
OnabotulinumtoxinA Injection | OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Botulinum toxin type A. |
RimabotulinumtoxinB Injection | RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Botulinum Toxin Type B. |
Doripenem Injection | Doripenem Injection Butabarbital may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection Butabarbital may increase the hypotensive activities of Arsenic trioxide. |
Desvenlafaxine | Desvenlafaxine The risk or severity of adverse effects can be increased when Butabarbital is combined with Desvenlafaxine. |
Cevimeline | Cevimeline Cevimeline may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Nebivolol | Nebivolol Butabarbital may increase the hypotensive activities of Nebivolol. |
Tretinoin | Tretinoin Butabarbital may increase the hypotensive activities of Tretinoin. |
Certolizumab Injection | Certolizumab Injection Butabarbital may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level. |
Daptomycin Injection | Daptomycin Injection Daptomycin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Methylnaltrexone Injection | Methylnaltrexone Injection Butabarbital may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Rufinamide | Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Butabarbital. |
Midazolam | Midazolam The risk or severity of adverse effects can be increased when Butabarbital is combined with Midazolam. |
Naltrexone Injection | Naltrexone Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Naltrexone. |
Dexrazoxane Injection | Dexrazoxane Injection Butabarbital may decrease the excretion rate of Dexrazoxane which could result in a higher serum level. |
Milnacipran | Milnacipran The risk or severity of adverse effects can be increased when Butabarbital is combined with Milnacipran. |
Plerixafor Injection | Plerixafor Injection Butabarbital may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Sodium Phosphate | Sodium Phosphate The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Butabarbital. |
Fesoterodine | Fesoterodine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine. |
Betaxolol | Betaxolol Butabarbital may increase the hypotensive activities of Betaxolol. |
Iloperidone | Iloperidone The risk or severity of adverse effects can be increased when Butabarbital is combined with Iloperidone. |
Prasugrel | Prasugrel Butabarbital may decrease the excretion rate of Prasugrel which could result in a higher serum level. |
Lacosamide | Lacosamide The risk or severity of adverse effects can be increased when Butabarbital is combined with Lacosamide. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
AbobotulinumtoxinA Injection | AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Botulinum toxin type A. |
Pralatrexate Injection | Pralatrexate Injection Butabarbital may decrease the excretion rate of Pralatrexate which could result in a higher serum level. |
Palonosetron Injection | Palonosetron Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Palonosetron. |
Saxagliptin | Saxagliptin Butabarbital may decrease the excretion rate of Saxagliptin which could result in a higher serum level. |
Telavancin Injection | Telavancin Injection Butabarbital may decrease the excretion rate of Telavancin which could result in a higher serum level. |
Tapentadol | Tapentadol Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Butabarbital. |
Topotecan | Topotecan Butabarbital may decrease the excretion rate of Topotecan which could result in a higher serum level. |
Asenapine | Asenapine The risk or severity of adverse effects can be increased when Butabarbital is combined with Asenapine. |
Vigabatrin | Vigabatrin The risk or severity of adverse effects can be increased when Butabarbital is combined with Vigabatrin. |
Ulipristal | Ulipristal The serum concentration of Ulipristal can be decreased when it is combined with Butabarbital. |
Oxymorphone | Oxymorphone The risk or severity of adverse effects can be increased when Butabarbital is combined with Oxymorphone. |
Dalfampridine | Dalfampridine Butabarbital may decrease the excretion rate of Dalfampridine which could result in a higher serum level. |
IncobotulinumtoxinA Injection | IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Botulinum toxin type A. |
Ceftaroline Injection | Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Lurasidone | Lurasidone The risk or severity of adverse effects can be increased when Butabarbital is combined with Lurasidone. |
Acetaminophen Injection | Acetaminophen Injection The metabolism of Acetaminophen can be increased when combined with Butabarbital. |
Vilazodone | Vilazodone The risk or severity of adverse effects can be increased when Butabarbital is combined with Vilazodone. |
Ipilimumab Injection | Ipilimumab Injection Butabarbital may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection Aldesleukin may increase the hypotensive activities of Butabarbital. |
Terbutaline Injection | Terbutaline Injection The therapeutic efficacy of Butabarbital can be decreased when used in combination with Terbutaline. |
Azilsartan | Azilsartan Butabarbital may increase the hypotensive activities of Azilsartan medoxomil. |
Roflumilast | Roflumilast Butabarbital may decrease the excretion rate of Roflumilast which could result in a higher serum level. |
Rivaroxaban | Rivaroxaban Butabarbital may decrease the excretion rate of Rivaroxaban which could result in a higher serum level. |
Ruxolitinib | Ruxolitinib Butabarbital may decrease the excretion rate of Ruxolitinib which could result in a higher serum level. |
Clobazam | Clobazam The risk or severity of adverse effects can be increased when Butabarbital is combined with Clobazam. |
Deferiprone | Deferiprone Butabarbital may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Cabergoline | Cabergoline The risk or severity of adverse effects can be increased when Butabarbital is combined with Cabergoline. |
Naloxone Injection | Naloxone Injection Butabarbital may decrease the excretion rate of Naloxone which could result in a higher serum level. |
Fondaparinux Injection | Fondaparinux Injection Butabarbital may decrease the excretion rate of Fondaparinux which could result in a higher serum level. |
Ezogabine | Ezogabine The risk or severity of adverse effects can be increased when Butabarbital is combined with Tiagabine. |
Iloprost | Iloprost Butabarbital may increase the hypotensive activities of Iloprost. |
Enzalutamide | Enzalutamide Butabarbital may decrease the excretion rate of Enzalutamide which could result in a higher serum level. |
Mirabegron | Mirabegron Butabarbital may decrease the excretion rate of Mirabegron which could result in a higher serum level. |
Linaclotide | Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Butabarbital. |
Teduglutide Injection | Teduglutide Injection Butabarbital may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Alogliptin | Alogliptin Butabarbital may decrease the excretion rate of Alogliptin which could result in a higher serum level. |
Pomalidomide | Pomalidomide The risk or severity of adverse effects can be increased when Butabarbital is combined with Pomalidomide. |
Canagliflozin | Canagliflozin The serum concentration of Canagliflozin can be decreased when it is combined with Butabarbital. |
Methazolamide | Methazolamide Methazolamide may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Trametinib | Trametinib Butabarbital may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran The risk or severity of adverse effects can be increased when Butabarbital is combined with Levomilnacipran. |
Ertapenem Injection | Ertapenem Injection Butabarbital may decrease the excretion rate of Ertapenem which could result in a higher serum level. |
Vortioxetine | Vortioxetine The risk or severity of adverse effects can be increased when Butabarbital is combined with Vortioxetine. |
Perampanel | Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Butabarbital. |
Ketorolac Injection | Ketorolac Injection Ketorolac may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Obinutuzumab Injection | Obinutuzumab Injection Butabarbital may increase the hypotensive activities of Obinutuzumab. |
Sofosbuvir | Sofosbuvir Butabarbital may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin Dapagliflozin may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Apremilast | Apremilast Butabarbital may decrease the excretion rate of Apremilast which could result in a higher serum level. |
Droxidopa | Droxidopa Butabarbital may decrease the excretion rate of Droxidopa which could result in a higher serum level. |
Eslicarbazepine | Eslicarbazepine The risk or severity of adverse effects can be increased when Butabarbital is combined with Eslicarbazepine. |
Testosterone Injection | Testosterone Injection Butabarbital may decrease the excretion rate of Testosterone which could result in a higher serum level. |
Empagliflozin | Empagliflozin Butabarbital may increase the hypotensive activities of Empagliflozin. |
Hydrocodone | Hydrocodone Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
Suvorexant | Suvorexant Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
Edoxaban | Edoxaban Butabarbital may decrease the excretion rate of Edoxaban which could result in a higher serum level. |
Methamphetamine | Methamphetamine The risk or severity of adverse effects can be increased when Butabarbital is combined with Metamfetamine. |
Tasimelteon | Tasimelteon The risk or severity of adverse effects can be increased when Butabarbital is combined with Tasimelteon. |
Riociguat | Riociguat Butabarbital may increase the hypotensive activities of Riociguat. |
Risperidone Injection | Risperidone Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Risperidone. |
Dinutuximab Injection | Dinutuximab Injection Butabarbital may increase the hypotensive activities of Dinutuximab. |
Haloperidol Injection | Haloperidol Injection The risk or severity of CNS depression can be increased when Butabarbital is combined with Haloperidol. |
Amiloride | Amiloride Amiloride may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Macitentan | Macitentan Butabarbital may decrease the excretion rate of Macitentan which could result in a higher serum level. |
Flibanserin | Flibanserin The risk or severity of adverse effects can be increased when Butabarbital is combined with Flibanserin. |
Brexpiprazole | Brexpiprazole The risk or severity of adverse effects can be increased when Butabarbital is combined with Brexpiprazole. |
Ziprasidone Injection | Ziprasidone Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Ziprasidone. |
Cariprazine | Cariprazine The risk or severity of adverse effects can be increased when Butabarbital is combined with Cariprazine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Butabarbital may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Eluxadoline | Eluxadoline The risk or severity of constipation can be increased when Butabarbital is combined with Eluxadoline. |
Ixazomib | Ixazomib Butabarbital may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Lesinurad | Lesinurad Butabarbital may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Brivaracetam Injection | Brivaracetam Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Brivaracetam. |
Pimavanserin | Pimavanserin The risk or severity of adverse effects can be increased when Butabarbital is combined with Pimavanserin. |
Diphenhydramine Injection | Diphenhydramine Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Diphenhydramine. |
Furosemide Injection | Furosemide Injection Butabarbital may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy. |
Lixisenatide Injection | Lixisenatide Injection Butabarbital may decrease the excretion rate of Lixisenatide which could result in a higher serum level. |
Doxepin (Insomnia) | Doxepin (Insomnia) Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Doxepin. |
Plecanatide | Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Butabarbital. |
Deutetrabenazine | Deutetrabenazine The risk or severity of sedation and somnolence can be increased when Butabarbital is combined with Deutetrabenazine. |
Valbenazine | Valbenazine Butabarbital may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Safinamide | Safinamide The risk or severity of adverse effects can be increased when Butabarbital is combined with Safinamide. |
Naldemedine | Naldemedine Butabarbital may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Benznidazole | Benznidazole Butabarbital may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Delafloxacin | Delafloxacin Butabarbital may decrease the excretion rate of Delafloxacin which could result in a higher serum level. |
Tetrabenazine | Tetrabenazine The risk or severity of sedation and somnolence can be increased when Butabarbital is combined with Tetrabenazine. |
Ertugliflozin | Ertugliflozin Ertugliflozin may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Buprenorphine Injection | Buprenorphine Injection Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
Apalutamide | Apalutamide Butabarbital may decrease the excretion rate of Apalutamide which could result in a higher serum level. |
Baricitinib | Baricitinib Butabarbital may decrease the excretion rate of Baricitinib which could result in a higher serum level. |
Lofexidine | Lofexidine The therapeutic efficacy of Butabarbital can be increased when used in combination with Lofexidine. |
Plazomicin Injection | Plazomicin Injection Butabarbital may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Cannabidiol | Cannabidiol The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butabarbital. |
Stiripentol | Stiripentol The risk or severity of adverse effects can be increased when Butabarbital is combined with Stiripentol. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection Butabarbital may increase the hypotensive activities of Paclitaxel. |
Prucalopride | Prucalopride Butabarbital may decrease the excretion rate of Prucalopride which could result in a higher serum level. |
Magnesium Citrate | Magnesium Citrate The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Butabarbital. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Brexanolone Injection | Brexanolone Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Brexanolone. |
Solriamfetol | Solriamfetol The risk or severity of adverse effects can be increased when Butabarbital is combined with Solriamfetol. |
Pitolisant | Pitolisant Butabarbital may decrease the excretion rate of Pitolisant which could result in a higher serum level. |
Phenytoin Injection | Phenytoin Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Phenytoin. |
Fosphenytoin Injection | Fosphenytoin Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Fosphenytoin. |
Lumateperone | Lumateperone The risk or severity of adverse effects can be increased when Butabarbital is combined with Lumateperone. |
Lasmiditan | Lasmiditan The risk or severity of adverse effects can be increased when Butabarbital is combined with Lasmiditan. |
Lemborexant | Lemborexant The risk or severity of adverse effects can be increased when Butabarbital is combined with Lemborexant. |
Fenfluramine | Fenfluramine The risk or severity of adverse effects can be increased when Butabarbital is combined with Fenfluramine. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Viloxazine | Viloxazine The risk or severity of adverse effects can be increased when Butabarbital is combined with Viloxazine. |
Tobramycin Injection | Tobramycin Injection Tobramycin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Theophylline | Theophylline The serum concentration of Theophylline can be decreased when it is combined with Butabarbital. |
Fenoprofen | Fenoprofen Fenoprofen may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Indomethacin | Indomethacin Indomethacin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Mefenamic Acid | Mefenamic Acid Mefenamic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Naproxen | Naproxen Naproxen may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Tolmetin | Tolmetin Tolmetin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Sulindac | Sulindac Sulindac may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Trazodone | Trazodone The risk or severity of adverse effects can be increased when Butabarbital is combined with Trazodone. |
Isotretinoin | Isotretinoin Butabarbital may decrease the excretion rate of Isotretinoin which could result in a higher serum level. |
Sucralfate | Sucralfate Butabarbital may decrease the excretion rate of Sucralfate which could result in a higher serum level. |
Floxuridine | Floxuridine Butabarbital may decrease the excretion rate of Floxuridine which could result in a higher serum level. |
Phenobarbital | Phenobarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Phenobarbital. |
Metaxalone | Metaxalone The risk or severity of adverse effects can be increased when Butabarbital is combined with Metaxalone. |
Methotrexate Injection | Methotrexate Injection Methotrexate may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Levorphanol | Levorphanol The risk or severity of adverse effects can be increased when Butabarbital is combined with Levorphanol. |
Primidone | Primidone The risk or severity of adverse effects can be increased when Butabarbital is combined with Primidone. |
Methsuximide | Methsuximide The risk or severity of adverse effects can be increased when Butabarbital is combined with Methsuximide. |
Diethylpropion | Diethylpropion The risk or severity of adverse effects can be increased when Butabarbital is combined with Diethylpropion. |
Chlorpromazine | Chlorpromazine Chlorpromazine may increase the hypotensive activities of Butabarbital. |
Diazepam | Diazepam The risk or severity of adverse effects can be increased when Butabarbital is combined with Diazepam. |
Oxazepam | Oxazepam The risk or severity of adverse effects can be increased when Butabarbital is combined with Oxazepam. |
Flurazepam | Flurazepam The risk or severity of adverse effects can be increased when Butabarbital is combined with Flurazepam. |
Clorazepate | Clorazepate The risk or severity of adverse effects can be increased when Butabarbital is combined with Clorazepic acid. |
Lorazepam | Lorazepam The risk or severity of adverse effects can be increased when Lorazepam is combined with Butabarbital. |
Phenoxybenzamine | Phenoxybenzamine Butabarbital may increase the hypotensive activities of Phenoxybenzamine. |
Carmustine | Carmustine Butabarbital may decrease the excretion rate of Carmustine which could result in a higher serum level. |
Amantadine | Amantadine Butabarbital may decrease the excretion rate of Amantadine which could result in a higher serum level. |
Codeine | Codeine The risk or severity of adverse effects can be increased when Butabarbital is combined with Codeine. |
Meprobamate | Meprobamate The risk or severity of adverse effects can be increased when Butabarbital is combined with Meprobamate. |
Chlordiazepoxide | Chlordiazepoxide The risk or severity of adverse effects can be increased when Butabarbital is combined with Chlordiazepoxide. |
Bromocriptine | Bromocriptine The risk or severity of adverse effects can be increased when Butabarbital is combined with Bromocriptine. |
Tranylcypromine | Tranylcypromine The risk or severity of adverse effects can be increased when Butabarbital is combined with Tranylcypromine. |
Phenelzine | Phenelzine The risk or severity of adverse effects can be increased when Butabarbital is combined with Phenelzine. |
Procarbazine | Procarbazine The risk or severity of adverse effects can be increased when Butabarbital is combined with Procarbazine. |
Ergoloid Mesylates | Ergoloid Mesylates The risk or severity of adverse effects can be increased when Butabarbital is combined with Ergoloid mesylate. |
Tetracycline | Tetracycline Butabarbital may decrease the excretion rate of Tetracycline which could result in a higher serum level. |
Minocycline | Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Butabarbital. |
Prochlorperazine | Prochlorperazine The risk or severity of adverse effects can be increased when Butabarbital is combined with Prochlorperazine. |
Thioridazine | Thioridazine The risk or severity of adverse effects can be increased when Butabarbital is combined with Thioridazine. |
Trifluoperazine | Trifluoperazine The risk or severity of adverse effects can be increased when Butabarbital is combined with Trifluoperazine. |
Bleomycin | Bleomycin Butabarbital may decrease the excretion rate of Bleomycin which could result in a higher serum level. |
Sulfadiazine | Sulfadiazine Butabarbital may decrease the excretion rate of Sulfadiazine which could result in a higher serum level. |
Oxycodone | Oxycodone The risk or severity of adverse effects can be increased when Butabarbital is combined with Oxycodone. |
Methadone | Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Butabarbital. |
Oxybutynin | Oxybutynin Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin. |
Benztropine | Benztropine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Benzatropine. |
Maprotiline | Maprotiline Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Maprotiline. |
Ibuprofen | Ibuprofen Ibuprofen may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Trihexyphenidyl | Trihexyphenidyl Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl. |
Orphenadrine | Orphenadrine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
Perphenazine | Perphenazine The risk or severity of adverse effects can be increased when Butabarbital is combined with Perphenazine. |
Azathioprine | Azathioprine Butabarbital may decrease the excretion rate of Azathioprine which could result in a higher serum level. |
Fluphenazine | Fluphenazine The risk or severity of adverse effects can be increased when Butabarbital is combined with Fluphenazine. |
Methylphenidate | Methylphenidate Butabarbital may decrease the excretion rate of Methylphenidate which could result in a higher serum level. |
Amoxapine | Amoxapine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Amoxapine. |
Sulfasalazine | Sulfasalazine Sulfasalazine may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Mechlorethamine | Mechlorethamine The therapeutic efficacy of Butabarbital can be decreased when used in combination with Mechlorethamine. |
Pyridostigmine | Pyridostigmine The therapeutic efficacy of Butabarbital can be decreased when used in combination with Pyridostigmine. |
Phenazopyridine | Phenazopyridine Phenazopyridine may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Carbamazepine | Carbamazepine Butabarbital may decrease the excretion rate of Carbamazepine which could result in a higher serum level. |
Molindone | Molindone The risk or severity of adverse effects can be increased when Butabarbital is combined with Molindone. |
Methyldopa | Methyldopa Butabarbital may increase the hypotensive activities of Methyldopa. |
Clonidine | Clonidine The risk or severity of sedation can be increased when Clonidine is combined with Butabarbital. |
Prazosin | Prazosin Butabarbital may increase the hypotensive activities of Prazosin. |
Hydralazine | Hydralazine Butabarbital may increase the hypotensive activities of Hydralazine. |
Cimetidine | Cimetidine Butabarbital may decrease the excretion rate of Cimetidine which could result in a higher serum level. |
Gentamicin Injection | Gentamicin Injection Gentamicin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Warfarin | Warfarin Butabarbital may decrease the excretion rate of Warfarin which could result in a higher serum level. |
Clonazepam | Clonazepam The risk or severity of adverse effects can be increased when Butabarbital is combined with Clonazepam. |
Loperamide | Loperamide The metabolism of Loperamide can be increased when combined with Butabarbital. |
Promethazine | Promethazine The risk or severity of adverse effects can be increased when Butabarbital is combined with Promethazine. |
Meclofenamate | Meclofenamate Meclofenamic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Nitrofurantoin | Nitrofurantoin Butabarbital may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level. |
Griseofulvin | Griseofulvin The serum concentration of Griseofulvin can be decreased when it is combined with Butabarbital. |
Digoxin | Digoxin Butabarbital may decrease the excretion rate of Digoxin which could result in a higher serum level. |
Loxapine | Loxapine The risk or severity of adverse effects can be increased when Butabarbital is combined with Loxapine. |
Chloroquine | Chloroquine Butabarbital may decrease the excretion rate of Chloroquine which could result in a higher serum level. |
Quinine | Quinine The risk or severity of adverse effects can be increased when Butabarbital is combined with Quinine. |
Ethosuximide | Ethosuximide The risk or severity of adverse effects can be increased when Butabarbital is combined with Ethosuximide. |
Triamterene | Triamterene Triamterene may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Lactulose | Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Butabarbital. |
Chlorothiazide | Chlorothiazide Chlorothiazide may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Chlorthalidone | Chlorthalidone Chlorthalidone may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Metolazone | Metolazone Butabarbital may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy. |
Isosorbide | Isosorbide Isosorbide may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Secobarbital | Secobarbital The risk or severity of adverse effects can be increased when Butabarbital is combined with Secobarbital. |
Desipramine | Desipramine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Desipramine. |
Amitriptyline | Amitriptyline Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline. |
Imipramine | Imipramine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Imipramine. |
Probenecid | Probenecid Butabarbital may decrease the excretion rate of Probenecid which could result in a higher serum level. |
Quinidine | Quinidine Butabarbital may decrease the excretion rate of Quinidine which could result in a higher serum level. |
Procainamide | Procainamide Procainamide may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Isoniazid | Isoniazid Butabarbital may decrease the excretion rate of Isoniazid which could result in a higher serum level. |
Pyrazinamide | Pyrazinamide Butabarbital may decrease the excretion rate of Pyrazinamide which could result in a higher serum level. |
Disopyramide | Disopyramide Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Disopyramide. |
Valproic Acid | Valproic Acid The serum concentration of Valproic acid can be increased when it is combined with Butabarbital. |
Liothyronine | Liothyronine Butabarbital may decrease the excretion rate of Liothyronine which could result in a higher serum level. |
Methimazole | Methimazole Butabarbital may decrease the excretion rate of Methimazole which could result in a higher serum level. |
Chlorpropamide | Chlorpropamide Butabarbital may decrease the excretion rate of Chlorpropamide which could result in a higher serum level. |
Tolbutamide | Tolbutamide Butabarbital may decrease the excretion rate of Tolbutamide which could result in a higher serum level. |
Tolazamide | Tolazamide Butabarbital may decrease the excretion rate of Tolazamide which could result in a higher serum level. |
Dextromethorphan | Dextromethorphan The risk or severity of adverse effects can be increased when Butabarbital is combined with Dextromethorphan. |
Cyclobenzaprine | Cyclobenzaprine The risk or severity of CNS depression can be increased when Butabarbital is combined with Cyclobenzaprine. |
Baclofen | Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Butabarbital. |
Doxylamine | Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Butabarbital. |
Cyproheptadine | Cyproheptadine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine. |
Clemastine | Clemastine The risk or severity of adverse effects can be increased when Butabarbital is combined with Clemastine. |
Chlorpheniramine | Chlorpheniramine The risk or severity of adverse effects can be increased when Butabarbital is combined with Chlorpheniramine. |
Brompheniramine | Brompheniramine The risk or severity of adverse effects can be increased when Butabarbital is combined with Dexbrompheniramine. |
Meclizine | Meclizine The risk or severity of adverse effects can be increased when Butabarbital is combined with Meclizine. |
Ethambutol | Ethambutol Butabarbital may decrease the excretion rate of Ethambutol which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide Methyclothiazide may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Hydrochlorothiazide | Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Dantrolene | Dantrolene The risk or severity of adverse effects can be increased when Butabarbital is combined with Dantrolene. |
Chlorzoxazone | Chlorzoxazone The risk or severity of adverse effects can be increased when Butabarbital is combined with Chlorzoxazone. |
Carisoprodol | Carisoprodol The risk or severity of adverse effects can be increased when Carisoprodol is combined with Butabarbital. |
Methocarbamol | Methocarbamol The risk or severity of adverse effects can be increased when Butabarbital is combined with Methocarbamol. |
Pyridoxine | Pyridoxine The metabolism of Butabarbital can be increased when combined with Pyridoxine. |
Folic Acid | Folic Acid Folic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) Butabarbital may increase the hypotensive activities of Propranolol. |
Minoxidil | Minoxidil Butabarbital may increase the hypotensive activities of Minoxidil. |
Nortriptyline | Nortriptyline Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline. |
Spironolactone | Spironolactone Spironolactone may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy. |
Amphotericin B Injection | Amphotericin B Injection Amphotericin B may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Mercaptopurine | Mercaptopurine The serum concentration of Mercaptopurine can be decreased when it is combined with Butabarbital. |
Phytonadione | Phytonadione Butabarbital may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Nadolol | Nadolol Butabarbital may increase the hypotensive activities of Nadolol. |
Butorphanol Injection | Butorphanol Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Butorphanol. |
Nalbuphine Injection | Nalbuphine Injection The risk or severity of adverse effects can be increased when Butabarbital is combined with Nalbuphine. |
Allopurinol | Allopurinol Butabarbital may decrease the excretion rate of Allopurinol which could result in a higher serum level. |
Trimethobenzamide | Trimethobenzamide The risk or severity of adverse effects can be increased when Butabarbital is combined with Trimethobenzamide. |
Flavoxate | Flavoxate Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Flavoxate. |
Papaverine | Papaverine Butabarbital may increase the hypotensive activities of Papaverine. |
Colchicine | Colchicine Butabarbital may decrease the excretion rate of Colchicine which could result in a higher serum level. |
Cefaclor | Cefaclor Cefaclor may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Cefadroxil | Cefadroxil Cefadroxil may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection Cefazolin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Cephalexin | Cephalexin Cephalexin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection Cefoxitin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Dacarbazine | Dacarbazine Butabarbital may decrease the excretion rate of Dacarbazine which could result in a higher serum level. |
Acetazolamide | Acetazolamide The risk or severity of adverse effects can be increased when Butabarbital is combined with Acetazolamide. |
Cefotaxime Injection | Cefotaxime Injection Cefotaxime may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Pyrantel | Pyrantel The risk or severity of adverse effects can be increased when Butabarbital is combined with Pyrantel. |
Thiotepa Injection | Thiotepa Injection The therapeutic efficacy of Butabarbital can be decreased when used in combination with Thiotepa. |
Captopril | Captopril Butabarbital may increase the hypotensive activities of Captopril. |
Dipyridamole | Dipyridamole Butabarbital may increase the hypotensive activities of Dipyridamole. |
Isoxsuprine | Isoxsuprine Butabarbital may increase the hypotensive activities of Isoxsuprine. |
Ethacrynic Acid | Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Colistimethate Injection | Colistimethate Injection Colistimethate may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Metoprolol | Metoprolol Butabarbital may increase the hypotensive activities of Metoprolol. |
Hydroxyzine | Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Butabarbital. |
Thiothixene | Thiothixene The risk or severity of adverse effects can be increased when Butabarbital is combined with Thiothixene. |
Aspirin | Aspirin Acetylsalicylic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Salsalate | Salsalate Salsalate may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Alprazolam | Alprazolam The risk or severity of adverse effects can be increased when Butabarbital is combined with Alprazolam. |
Temazepam | Temazepam The risk or severity of adverse effects can be increased when Temazepam is combined with Butabarbital. |
Triazolam | Triazolam The risk or severity of adverse effects can be increased when Butabarbital is combined with Triazolam. |
Dicyclomine | Dicyclomine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine. |
Hyoscyamine | Hyoscyamine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine. |
Propantheline | Propantheline Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Propantheline. |
Trimethoprim | Trimethoprim Butabarbital may decrease the excretion rate of Trimethoprim which could result in a higher serum level. |
Diltiazem | Diltiazem Butabarbital may increase the hypotensive activities of Diltiazem. |
Nifedipine | Nifedipine Butabarbital may increase the hypotensive activities of Nifedipine. |
Timolol | Timolol Butabarbital may increase the hypotensive activities of Timolol. |
Verapamil | Verapamil Butabarbital may increase the hypotensive activities of Verapamil. |
Atenolol | Atenolol Butabarbital may increase the hypotensive activities of Atenolol. |
Pindolol | Pindolol The risk or severity of adverse effects can be increased when Butabarbital is combined with Pindolol. |
Cisplatin Injection | Cisplatin Injection Cisplatin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Diflunisal | Diflunisal Diflunisal may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Piroxicam | Piroxicam Piroxicam may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Bumetanide | Bumetanide Butabarbital may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy. |
Glipizide | Glipizide Butabarbital may decrease the excretion rate of Glipizide which could result in a higher serum level. |
Indapamide | Indapamide Butabarbital may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy. |
Amoxicillin | Amoxicillin Butabarbital may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Butabarbital may decrease the excretion rate of Oxacillin which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline The serum concentration of Pentoxifylline can be decreased when it is combined with Butabarbital. |
Pentamidine Injection | Pentamidine Injection Pentamidine may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Ceftriaxone Injection | Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Labetalol | Labetalol Butabarbital may increase the hypotensive activities of Labetalol. |
Auranofin | Auranofin Butabarbital may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection Leuprolide may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Gemfibrozil | Gemfibrozil Butabarbital may decrease the excretion rate of Gemfibrozil which could result in a higher serum level. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Ceftazidime Injection | Ceftazidime Injection Ceftazidime may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Ketoprofen | Ketoprofen Ketoprofen may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Cefotetan Injection | Cefotetan Injection Cefotetan may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Pimozide | Pimozide The risk or severity of adverse effects can be increased when Butabarbital is combined with Pimozide. |
Enalapril | Enalapril Butabarbital may increase the hypotensive activities of Enalapril. |
Flurbiprofen | Flurbiprofen Flurbiprofen may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Amiodarone | Amiodarone Butabarbital may increase the hypotensive activities of Amiodarone. |
Aztreonam Injection | Aztreonam Injection Butabarbital may decrease the excretion rate of Aztreonam which could result in a higher serum level. |
Buspirone | Buspirone Butabarbital may decrease the excretion rate of Buspirone which could result in a higher serum level. |
Ciprofloxacin | Ciprofloxacin Butabarbital may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level. |
Mesalamine | Mesalamine Mesalazine may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Diclofenac | Diclofenac Diclofenac may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Fluoxetine | Fluoxetine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine. |
Nimodipine | Nimodipine Butabarbital may increase the hypotensive activities of Nimodipine. |
Clozapine | Clozapine The risk or severity of adverse effects can be increased when Butabarbital is combined with Clozapine. |
Estazolam | Estazolam The risk or severity of adverse effects can be increased when Butabarbital is combined with Estazolam. |
Didanosine | Didanosine Butabarbital may decrease the excretion rate of Didanosine which could result in a higher serum level. |
Pentostatin Injection | Pentostatin Injection Butabarbital may decrease the excretion rate of Pentostatin which could result in a higher serum level. |
Benazepril | Benazepril Butabarbital may increase the hypotensive activities of Benazepril. |
Etodolac | Etodolac Etodolac may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Felodipine | Felodipine Butabarbital may increase the hypotensive activities of Felodipine. |
Fosinopril | Fosinopril Butabarbital may increase the hypotensive activities of Fosinopril. |
Nabumetone | Nabumetone Nabumetone may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Quinapril | Quinapril Butabarbital may increase the hypotensive activities of Quinapril. |
Ramipril | Ramipril Ramipril may increase the hypotensive activities of Butabarbital. |
Amlodipine | Amlodipine Butabarbital may increase the hypotensive activities of Amlodipine. |
Teniposide Injection | Teniposide Injection The serum concentration of Teniposide can be decreased when it is combined with Butabarbital. |
Lisinopril | Lisinopril Butabarbital may increase the hypotensive activities of Lisinopril. |
Oxaprozin | Oxaprozin Oxaprozin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Sotalol | Sotalol Butabarbital may increase the hypotensive activities of Sotalol. |
Bisoprolol | Bisoprolol Butabarbital may increase the hypotensive activities of Bisoprolol. |
Zolpidem | Zolpidem Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
Doxazosin | Doxazosin Butabarbital may increase the hypotensive activities of Doxazosin. |
Terazosin | Terazosin Butabarbital may increase the hypotensive activities of Terazosin. |
Isradipine | Isradipine Butabarbital may increase the hypotensive activities of Isradipine. |
Cisapride | Cisapride The risk or severity of adverse effects can be increased when Butabarbital is combined with Cisapride. |
Gabapentin | Gabapentin The risk or severity of adverse effects can be increased when Butabarbital is combined with Gabapentin. |
Venlafaxine | Venlafaxine The risk or severity of adverse effects can be increased when Butabarbital is combined with Venlafaxine. |
Nizatidine | Nizatidine The therapeutic efficacy of Butabarbital can be decreased when used in combination with Nizatidine. |
Fluvoxamine | Fluvoxamine The risk or severity of adverse effects can be increased when Butabarbital is combined with Fluvoxamine. |
Nefazodone | Nefazodone The risk or severity of adverse effects can be increased when Butabarbital is combined with Nefazodone. |
Lamotrigine | Lamotrigine The serum concentration of Lamotrigine can be decreased when it is combined with Butabarbital. |
Losartan | Losartan Butabarbital may increase the hypotensive activities of Losartan. |
Valacyclovir | Valacyclovir Valaciclovir may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Tramadol | Tramadol The risk or severity of CNS depression can be increased when Butabarbital is combined with Tramadol. |
Carboplatin Injection | Carboplatin Injection Carboplatin may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Moexipril | Moexipril Butabarbital may increase the hypotensive activities of Moexipril. |
Ifosfamide Injection | Ifosfamide Injection Butabarbital may decrease the excretion rate of Ifosfamide which could result in a higher serum level. |
Nicardipine | Nicardipine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Nicardipine. |
Bupropion | Bupropion The risk or severity of adverse effects can be increased when Butabarbital is combined with Bupropion. |
Ticlopidine | Ticlopidine Ticlopidine may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Metformin | Metformin Butabarbital may decrease the excretion rate of Metformin which could result in a higher serum level. |
Nisoldipine | Nisoldipine Butabarbital may increase the hypotensive activities of Nisoldipine. |
Lamivudine | Lamivudine Butabarbital may decrease the excretion rate of Lamivudine which could result in a higher serum level. |
Riluzole | Riluzole The risk or severity of adverse effects can be increased when Butabarbital is combined with Riluzole. |
Amifostine Injection | Amifostine Injection Butabarbital may increase the hypotensive activities of Amifostine. |
Acarbose | Acarbose Butabarbital may decrease the excretion rate of Acarbose which could result in a higher serum level. |
Gemcitabine Injection | Gemcitabine Injection Butabarbital may decrease the excretion rate of Gemcitabine which could result in a higher serum level. |
Cidofovir Injection | Cidofovir Injection Cidofovir may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Butabarbital may decrease the excretion rate of Meropenem which could result in a higher serum level. |
Clomipramine | Clomipramine The risk or severity of adverse effects can be increased when Butabarbital is combined with Clomipramine. |
Fosfomycin | Fosfomycin Butabarbital may decrease the excretion rate of Fosfomycin which could result in a higher serum level. |
Mirtazapine | Mirtazapine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
Trandolapril | Trandolapril Butabarbital may increase the hypotensive activities of Trandolapril. |
Topiramate | Topiramate The risk or severity of adverse effects can be increased when Butabarbital is combined with Topiramate. |
Valsartan | Valsartan Butabarbital may increase the hypotensive activities of Valsartan. |
Pramipexole | Pramipexole Butabarbital may increase the sedative activities of Pramipexole. |
Donepezil | Donepezil The therapeutic efficacy of Butabarbital can be decreased when used in combination with Donepezil. |
Loratadine | Loratadine Butabarbital may increase the anticholinergic activities of Loratadine. |
Carvedilol | Carvedilol Butabarbital may increase the hypotensive activities of Carvedilol. |
Nilutamide | Nilutamide Butabarbital may decrease the excretion rate of Nilutamide which could result in a higher serum level. |
Flutamide | Flutamide Butabarbital may decrease the excretion rate of Flutamide which could result in a higher serum level. |
Selegiline | Selegiline The risk or severity of adverse effects can be increased when Butabarbital is combined with Selegiline. |
Sertraline | Sertraline The risk or severity of adverse effects can be increased when Butabarbital is combined with Sertraline. |
Propafenone | Propafenone The serum concentration of Propafenone can be decreased when it is combined with Butabarbital. |
Irbesartan | Irbesartan Butabarbital may increase the hypotensive activities of Irbesartan. |
Tamsulosin | Tamsulosin Butabarbital may increase the hypotensive activities of Tamsulosin. |
Ropinirole | Ropinirole Butabarbital may increase the sedative activities of Ropinirole. |
Quetiapine | Quetiapine The risk or severity of adverse effects can be increased when Butabarbital is combined with Quetiapine. |
Cefepime Injection | Cefepime Injection Cefepime may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Cefprozil | Cefprozil Cefprozil may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Cefpodoxime | Cefpodoxime Cefpodoxime may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Cetirizine | Cetirizine The risk or severity of adverse effects can be increased when Butabarbital is combined with Cetirizine. |
Paroxetine | Paroxetine The risk or severity of adverse effects can be increased when Butabarbital is combined with Paroxetine. |
Tolcapone | Tolcapone The risk or severity of adverse effects can be increased when Butabarbital is combined with Tolcapone. |
Citalopram | Citalopram The risk or severity of adverse effects can be increased when Butabarbital is combined with Citalopram. |
Capecitabine | Capecitabine Butabarbital may decrease the excretion rate of Capecitabine which could result in a higher serum level. |
Efavirenz | Efavirenz The risk or severity of adverse effects can be increased when Butabarbital is combined with Efavirenz. |
Abacavir | Abacavir Butabarbital may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Celecoxib | Celecoxib Celecoxib may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Rosiglitazone | Rosiglitazone Butabarbital may decrease the excretion rate of Rosiglitazone which could result in a higher serum level. |
Tolterodine | Tolterodine Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Tolterodine. |
Thalidomide | Thalidomide Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
Oseltamivir | Oseltamivir Oseltamivir may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Balsalazide | Balsalazide Balsalazide may decrease the excretion rate of Butabarbital which could result in a higher serum level. |
Nateglinide | Nateglinide Butabarbital may decrease the excretion rate of Nateglinide which could result in a higher serum level. |
Galantamine | Galantamine The therapeutic efficacy of Butabarbital can be decreased when used in combination with Galantamine. |
Levetiracetam | Levetiracetam The risk or severity of adverse effects can be increased when Butabarbital is combined with Levetiracetam. |
Rabeprazole | Rabeprazole Butabarbital may decrease the excretion rate of Rabeprazole which could result in a higher serum level. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists